Showing posts with label drug. Show all posts
Showing posts with label drug. Show all posts

Thursday, 20 July 2017

Actor and songwriter Robert Gene 'Red' West dies at 81

Red West

Actor and songwriter Robert Gene "Red" West, a longtime confidant of Elvis Presley, has died in Memphis.

Danita Allen of Memorial Park Funeral Home said West died Tuesday. He was 81. His wife, Pat West, told The Commercial Appeal he died at Baptist Hospital after suffering from an aortic aneurysm.

West met Presley in high school and worked for him for 20 years. He was a friend, driver and bodyguard. He also took small roles in some of Presley's films and co-wrote some songs Presley sang including "Separate Ways" and "If You Talk In Your Sleep."

After West was fired by Presley's father in 1976, he went on to help write a book called "Elvis: What Happened?" The book, published shortly before Presley's death, included details about the singer's drug dependency and unhealthy lifestyle.

West and his co-authors, Sonny West and David Hebler, said the book was an attempt to encourage Elvis to give up his dangerous ways. However, some fans said it was written out of spite because they were fired.

Afterward, West became a full-time actor and appeared on TV shows and in movies. His most famous role was in 1989's "Road House" starring Patrick Swayze.

Wednesday, 15 March 2017

Delhi HC upholds order restricting sale of Cipla's respiratory disease drug

An employee works at the reception area of Cipla at its headquarters in Mumbai
Latest News - A division bench of the Delhi High Court on Thursday upheld a single judge order restraining Cipla from selling its respiratory disease drug – Indaflo.  Cipla had launched the drug in the Indian market in 2014 under the name Unibrez, while also calling for the revocation of five Novartis patents on Indacaterol, the generic version of the respiratory medicine. 

Cipla later had to change the name Unibrez to Indaflo, after a court order held the earlier name as infringing on the trademark of Novartis’s own variant – Onbrez. After winning the first round in court, Novartis filed a separate suit for permanent injunction claiming the infringement of its patent on Indacaterol by Cipla. 

Novartis’s bid to stop Cipla from selling Indacaterol in its entirety became a reality after a single judge bench in January 2015, restrained Cipla from selling their version of the drug, until otherwise allowed a compulsory license to sell the medicine from a (Read More)